Clinical Trial Update: To Evaluate Pharmacokinetics of LFF269 in Healthy Volunteers and Patients With Hypertension [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study of the investigative drug LFF269 in healthy volunteers and patients with hypertension; the trial status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• LFF269

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Part 1 - Healthy Volunteers, Part 2 - Patients With Hypertension | Phase 1 | Status: TERMINATED